Author

James L. Young

Observed names: J.L. Young, Young, James L.

Institution: University of Massachusetts Chan Medical School

Observed institutions: Brigham and Women's Hospital, Harvard University, University of Massachusetts Chan Medical School

OpenAlex ID: A5111974483

Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages

2002 · Norbert Gerdes, Galina K. Sukhova, et al. · The Journal of Experimental Medicine · 509

Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells

2005 · Kikuo Isoda, James L. Young, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 498

The Serpin Proteinase Inhibitor 9 Is an Endogenous Inhibitor of Interleukin 1β–Converting Enzyme (Caspase-1) Activity in Human Vascular Smooth Muscle Cells

2000 · James L. Young, Galina K. Sukhova, et al. · The Journal of Experimental Medicine · 133

CD14 Deficiency Impacts Glucose Homeostasis in Mice through Altered Adrenal Tone

2012 · James L. Young, Alfonso Mora, et al. · PLoS ONE · 24

Tu-W24:4 Metformin inhibits proinflammatory responses in human vascular wall cells: Inhibition of nuclear factor-kappa B signaling in smooth muscle cells

2006 · J.L. Young, K. Isoda, et al. · Atherosclerosis Supplements · 3

Innate Immunity in Type 2 Diabetes Pathogenesis: Role of the Lipopolysaccharide Signaling Cascade: A Dissertation

2008 · Young, James L. · The Journal of the American Medical Association (JAMA) Network (American Medical Association)

Human vascular smooth muscle cells express an endogenous inhibitor of Caspase-1

2000 · U. Schönbeck, J.L. Young, et al. · Atherosclerosis

Works count: 7

Citation count: 1,167

H-index: 4

I10-index: 4